| Customization: | Available |
|---|---|
| CAS No.: | N/a |
| Formula: | N/a |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | PTD-DBM |
| CAS number | N/A |
| Grade | Cosmetic grade, pharma grade |
| Appearance | White powder |
| Purity | 99.0% |
| Description | PTD-DBM is a peptide activating the Wnt/β-catenin signaling pathway functioning via interference of the binding of CXXC5 to Dishevelled (Dvl), an upstream component of the Wnt/β-catenin pathway. By topical application, the PTD-DBM promotes the formation of new hair follicles and prevents hair loss. Combinatory treatment of PTD-DBM with valproic acid (VPA), the activator of Wnt/β-catenin pathway, further induce hair re-growth as well as wound-induced hair neogenesis (WIHN). |
PTD-DBM which is short for Protein transduction domain (PTD)-Dvl-binding motif (DBM).
In simple terms, it is a follicle regeneration treatment. More specifically, it is a peptide-based topical scalp treatment which inhibits the follicle shrinking action of the body's hormones and enzymes effectively rescuing the follicle at a stem cell level. Treatment with PTD-DBM both prevents hair loss and promotes the growth of new hair follicles.
Many researchers believe that WNT signaling pathways inside of a cell are responsible for hair follicle development and hair regeneration in humans. These pathways are usually made of proteins and they communicate important cell activity and growth signals to various cells throughout our body.
){kind=link}